Dahlia Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dahlia Biosciences, Inc. - overview
Established
2017
Location
San Francisco, CA, US
Primary Industry
Biotechnology
About
Founded in 2017 and based in California, US, Dahlia Biosciences, Inc. is a biotechnology company that develops single-cell RNA analysis tools for diagnostic and research applications.
Current Investors
SOSV, IndieBio
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Diagnostic, Medical & Imaging Laboratories
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.